Clincosm LogoSign in Get a demo

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

Sponsor
Qilu Hospital of Shandong University (Other)
Overall Status
Completed
CT.gov ID
NCT05550805
Collaborator
(none)
666
Enrollment
1
Location
51.9
Actual Duration (Months)
12.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To investigate whether there were differences in metabolomics and lipidomics in patients with coronary artery disease who had major adverse cardiovascular events during follow-up compared with those who did not.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    666 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics
    Actual Study Start Date :
    Nov 1, 2017
    Actual Primary Completion Date :
    Mar 1, 2022
    Actual Study Completion Date :
    Mar 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. major adverse cardiovascular events [20191101-20220701]

      cardiac death, myocardial infarction, heart failure, stroke

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    29 Years to 86 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1. Hospitalized patients with the diagnosis of any type of coronary artery disease;

    2. Age ≥18 years of age;

    3. Patient or guardian provided informed written consent.

    Exclusion Criteria:

    1. Prior surgery, trauma or clinically evident coagulopathic bleeding within the previous 2 weeks;

    2. Bipass population with missing follow-up records in Qilu Hospital emergency follow-up cohort.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yuguo Chen Jinan Shandong China 250012

    Sponsors and Collaborators

    • Qilu Hospital of Shandong University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Qilu Hospital of Shandong University
    ClinicalTrials.gov Identifier:
    NCT05550805
    Other Study ID Numbers:
    • 20220914-Qilu
    First Posted:
    Sep 22, 2022
    Last Update Posted:
    Sep 22, 2022
    Last Verified:
    Sep 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Coronary Artery Disease
    Myocardial Ischemia
    Coronary Disease

    Study Results

    No Results Posted as of Sep 22, 2022